Blog
2 Soaring Stocks to Hold for the Next 20 Years
It's tempting to avoid stocks whose prices have gone up a lot. After all, you may feel you've missed the boat.
But if a company has bright growth prospects, it's a sound money-making strategy to
The Window to Change Your Medicare Advantage Plan Is Quickly Closing. Here's What You Need to Know.
A lot of people choose to enroll in a Medicare Advantage plan over original Medicare. And it's easy to see why.
With Medicare Advantage, you often get supplemental benefits that original Medicare
2 Tech Stocks That Could Help Make You a Fortune
Building wealth in the stock market is fairly simple if you maintain a long-term mindset and focus on stocks of competitively positioned businesses. Investing in innovative companies with
The Top Nuclear Energy Stock to Buy in March
The world's first nuclear power plant opened in 1951. But despite the potential of the technology to deliver large quantities of clean energy, it remained less popular than oil, natural gas, and
1 Growth Stock Dynamo to Buy Before It Soars Past $8 Trillion, According to 1 Wall Street Analyst
When it rains, it pours. Investors already had plenty to worry about, with rising prices, political dysfunction, and now, the Strait of Hormuz is entering the popular vocabulary. People face this
3 Latin American Fintechs That Are Growing Faster Than You Think
Every fintech is not the same. Even if you narrow your focus to Latin America, MercadoLibre (NASDAQ: MELI), DLocal (NASDAQ: DLO), and Nu Holdings (NYSE: NU) are three very different companies. There
Arlo Technologies General Counsel Sells 25000 Shares for $352000 to Cover Taxes
Brian Busse, General Counsel of Arlo Technologies (NYSE:ARLO), reported the sale of 25,525 direct shares for approximately $352K following the addition of shares on March 12, 2026, according to a
The Pentagon Just Dropped a Bombshell for Palantir Stock Investors
Palantir Technologies (NASDAQ: PLTR) has been one of the most controversial stocks of the past few years. The company developed data mining infused with Palantir's proprietary artificial
The Fintech Stock Wall Street Insiders Are Quietly Buying
Alkami Technology (NASDAQ: ALKT), a cloud-based digital banking platform, has seen its share price plummet since the end of 2024. A combination of factors, including three earnings misses last year
2 Defensive Healthcare Stocks to Buy Right Now
The S&P 500 soared over the past three years -- but since the start of this year, the benchmark has lost some of the positive momentum. This is for a variety of reasons. The possibility that the
Top Stocks to Double Up on Right Now
Shares in Diamondback Energy (NASDAQ: FANG) and Valero Energy (NYSE: VLO) have risen strongly in 2026, partly in response to hostilities in the Gulf and the resulting increase in oil prices.
Live Oak Bancshares CEO Sells 20000 Shares for $653000
James S. Mahan III, Chief Executive Officer of Live Oak Bancshares (NYSE:LOB), reported the indirect sale of 20,000 shares of Common Stock for a transaction value of approximately $653,000 across
Bold Prediction: SMH Is About to Soar. Here's Why.
U.S. equities have seen some volatility in 2026, but they've mostly been able to hold up relatively well. The conflict in Iran is adding a layer of uncertainty to the markets, but that could also
1 Tesla Competitor That Could Unseat the EV Giant by 2029
In many ways, Tesla (NASDAQ: TSLA) has faced limited competition over the last decade. Limited competition is a big reason why the company still commands a U.S. market share of more than 50%.
Sure
Where Will Palantir Stock Be in 3 Years?
Palantir Technologies (NASDAQ: PLTR) has been one of the hottest stocks over the past three years, as the company has seen its revenue growth accelerate for 10 straight quarters. The question on
Better Asset to Buy Now With $500 and Hold for 3 Years: Bitcoin vs. Gold
The SPDR Gold Shares (NYSEMKT: GLD) exchange-traded fund (ETF) is up by 60% in the last 12 months, putting most other major assets to shame. Meanwhile, Bitcoin (CRYPTO: BTC), the asset that some
Is the Vanguard S&P 500 ETF the Smartest Investment You Can Make Before March Ends?
Despite the volatility we've seen in the equity markets this year, the S&P 500 (SNPINDEX: ^GSPC) has mostly traded sideways. Its year-to-date return has only varied between up 2% to 3% and down
Rumble (RUM) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, March 5, 2026 at 5 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Prediction: While Big Tech Grabs Headlines, These Small AI Stocks Could Outperform
Perhaps no stock has symbolized the artificial intelligence (AI) era more than Nvidia. Thanks to AI, it became the first company to reach a $4 trillion market cap, then beat its own record a few
Global Partners LP COO Sells Nearly $740000 Worth of Units
Mark Romaine, Chief Operating Officer of Global Partners LP (NYSE:GLP), reported the direct sale of 15,611 common units across multiple transactions between March 16 and March 18, 2026, as disclosed
The Social Security Fairness Act Paid Out $17 Billion in Retroactive Benefits. Here's Who Qualifies.
Signed into law on Jan. 5, 2025, the Social Security Fairness Act represents one of the most significant changes to America's retirement system in recent history. At its core, the legislation
The Tech Stock With More Potential Than Any Cryptocurrency
Cryptocurrency has been having a rough year. Since peaking at over $122,000 late last year, Bitcoin has tumbled to $73,986. Year to date, it's down 15.3% and dipped below $64,000 last month.
Now
Could Buying $10,000 of Sandisk Make You a Millionaire?
Sandisk (NASDAQ: SNDK) has been on one heck of a run since its spinoff from Western Digital (NASDAQ: WDC) last year. The flash-memory maker's stock has climbed nearly 2,000% since its market debut
Better Cybersecurity Stock: Okta vs. Zscaler
If you spend your workdays in front of a computer, there's a solid chance you're required to keep your company safe from bad actors through either Okta (NASDAQ: OKTA) or Zscaler (NASDAQ: ZS). Both
Maze Therapeutics President Sells All Insider Shares as Q4 Earning Report Nears
On March 10, 2026, Harold Bernstein, President, R&D & Chief Medical Officer of Maze Therapeutics (NASDAQ:MAZE), reported the exercise of 30,000 stock options and immediate sale of the underlying


